Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoer Xiaoshi Granules is a Traditional Chinese Medicine (TCM) developed and manufactured by Hefei Everlife Pharmaceutical, specifically indicated for the treatment of pediatric indigestion. The formulation is designed to invigorate the spleen, regulate the stomach, and eliminate food stagnation, addressing symptoms such as loss of appetite, abdominal distension, and sour regurgitation in children. As a TCM product, it typically comprises a blend of herbal ingredients known for their digestive properties, such as Hawthorn (*Crataegi Fructus*), Medicated Leaven (*Massa Medicata Fermentata*), and Malt (*Hordei Fructus Germinatus*). It is administered orally as granules and is currently approved and marketed in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiaoer xiaoshi granules.